Suppression of YAP by DDP disrupts colon tumor progression.

about

Suppression of YAP by DDP disrupts colon tumor progression.

Item

http://www.wikidata.org/entity/Q52728270

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Suppression of YAP by DDP disrupts colon tumor progression.

@en

Suppression of YAP by DDP disrupts colon tumor progression.

@nl

type

Item

label

Suppression of YAP by DDP disrupts colon tumor progression.

@en

Suppression of YAP by DDP disrupts colon tumor progression.

@nl

prefLabel

Suppression of YAP by DDP disrupts colon tumor progression.

@en

Suppression of YAP by DDP disrupts colon tumor progression.

@nl

P1476

Suppression of YAP by DDP disrupts colon tumor progression.

@en

P2093

Chengxia Liu

http://www.w3.org/2001/XMLSchema#string

Chengyong Qin

http://www.w3.org/2001/XMLSchema#string

Dan Jin

http://www.w3.org/2001/XMLSchema#string

Hong Jiang

http://www.w3.org/2001/XMLSchema#string

Jiwei Guo

http://www.w3.org/2001/XMLSchema#string

Kun Li

http://www.w3.org/2001/XMLSchema#string

Yan Wu

http://www.w3.org/2001/XMLSchema#string

P2860

YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response

Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-small-cell lung cancer

Regulation of localization and function of the transcriptional co-activator YAP by angiomotin.

Anti-cancer effect of Scutellaria baicalensis in combination with cisplatin in human ovarian cancer cell.

Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.

The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity

Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology.

Preclinical data on the combination of cisplatin and anti-CD70 therapy in non-small cell lung cancer as an excellent match in the era of combination therapy.

The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells.

Zyxin-Siah2-Lats2 axis mediates cooperation between Hippo and TGF-β signalling pathways

P304

2114-2126

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2018.6297

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29512779

http://www.w3.org/2001/XMLSchema#string

P932

5928767

http://www.w3.org/2001/XMLSchema#string